This latest research comes at a time when people with diabetes and other underlying underlying diseases are six times more likely to be hospitalized and 12 times more likely to die from COVID-19 than those without. In addition, diabetes is the second most commonly reported underlying health condition among COVID-19 patients in the United States
“In the past 16 months, the need for diabetes awareness and care has grown rapidly as diabetes is recognized as a major risk factor for serious complications from COVID-19. Given the devastating impact the pandemic has had on people with diabetes, the ADA has been encouraged to work even harder to lead the fight against diabetes. Our mission is reinforced by researchers from around the world who are committed to carefully examining specific effects and interventions to help people with diabetes in this COVID-19 era, “said Dr. Robert Gabbay, MD, PhD, Chief Scientific & Medical Officer of the ADA. “We look forward to showing this in five comprehensive symposia to share important insights and lay the foundation for future patient care.”
Each symposium will highlight the impact of COVID-19 on diabetes care, with topics ranging from treating COVID-19 long-distance drivers to treating COVID-19 and health inequalities, obesity, telemedicine and mental health in people with diabetes. Below is a schedule for COVID-19 symposia. After each symposium there will be a live question and answer where the media and attendees can speak to leading researchers.
In addition to the COVID-19 symposia, the ADA also organizes an exclusive press event on Monday June 28th at the 7:00 p.m. ET about COVID-19 and diabetes. The event will present initial results from two studies that are part of $ 1 million Investing in research into the link between COVID-19 and diabetes. Find out more about the event or register.
Friday June 25th, 2:00 p.m.-3: 45 p.m. ET
COVID-19 and Diabetes – An Update
Chair: Rodolfo J. Galindo, MD, Emory University
- Role of hyperglycemia in COVID-19 outcomes
- COVID-19 and emerging diabetes – expose type 2 diabetes, trigger autoimmunity, or both?
- Remote monitoring of COVID-19 patients through continuous glucose monitoring
Saturday June 26th, 8:00 am-9:25 pm ET
ADA Diabetes Care Symposium – Learning to Minimize Risks for People with Diabetes in the COVID-19 Pandemic
Chair: Matthew C. Riddle, MD, Oregon Health & Science University
- Diabetes and COVID-19 after 18 months – trouble ahead, trouble behind
- COVID-19 and Type 1 Diabetes – Maintaining Control and Addressing Concerns
- Presentation of the Profiles in Progress Awards
Sunday June 27th, 2:15 pm-3:45pm ET
Efficacy and safety of dapagliflozin in patients with and without type 2 diabetes who were hospitalized with COVID-19 – results of the global randomized controlled trial DARE-19
Chair: Jennifer B. Green, MD, Duke University
- Rationale, design and baseline characteristics of the patients in the DARE-19 study
- Efficacy results in patients with and without type 2 diabetes
- Safety results in patients with and without type 2 diabetes
- Clinical implications of the DARE-19 study
Sunday June 27th4: 30-6: 30pm ET
When COVID-19 Collides with Diabetes – Data and Experience on the Impact on People with Diabetes
Chair: Shivani Agarwal, MD, MPH, Albert Einstein College of medicine
- Assessing the intersection of COVID-19, diabetes, and mental health in adults with diabetes
- The effects of COVID-19 on the most medically and socially vulnerable adolescents with diabetes
- Diabetes Management in African American Adults During a Pandemic – Lessons from Detroit, MI – a COVID-19 epicenter in the United States
- Effects of COVID-19 on Psychosocial and Behavioral Factors – Assessment of Parents of Young Children with Diabetes
Monday June 28th4: 30-6: 30pm ET
COVID-19, diabetes and obesity
Chair: Kamlesh Khunti, PhD, MD, FRCGP, FRCP, FMedSci, University of Leicester
- Obesity and Diabetes – Risk Factors for Severe COVID-19
- Coronaviruses – dysregulation of the immune response in diabetes mellitus
- Hyperglycemia and Severe COVID-19
- Glycolysis, interferons and SARS-CoV-2 infection
To attend the ADA’s 81st Scientific Scientific Sessions, visit the official registration information page for more details. Press representatives should apply for press registration. Registration includes access to all sessions during the five-day meeting and unrestricted access to all virtual content for 90 days after the meeting dates.
For further information or interview requests, please contact the media team of the Scientific Sessions at [email protected].
About the scientific meetings of the ADA
The 81st Scientific Sessions of the ADA, the world’s largest scientific conference with a focus on diabetes research, prevention and care, will take place from June 25th to 29th. Leading doctors, scientists and healthcare professionals from around the world will share cutting-edge research, treatment recommendations and advances in curing diabetes. Although the conference will not take place this year, attendees will get exclusive access to nearly 2,000 original research presentations and partake in a provocative and engaging exchange with leading diabetes experts. Learn more and register at Scientificsessions.diabetes.org and join the discussion of Scientific Sessions on social media at # ADA2021.
Via the American Diabetes Association
More than 4,000 people are newly diagnosed with diabetes in America every day. More than 122 million Americans have diabetes or prediabetes and struggle to manage their lives while living with the disease. The ADA is the country’s leading voluntary health organization fighting to end the diabetes epidemic and help people with diabetes thrive. For 80 years, the ADA has advanced discovery and research into the treatment, treatment, and prevention of diabetes while working tirelessly to find a cure. We help people with diabetes thrive by fighting for their rights and developing programs, advocacy and education to improve their quality of life. Diabetes brought us together, what we do next will make us Connected for Life. To learn more or to get involved, visit us at diabetes.org or call 1-800-DIABETES (1-800-342-2383). Get involved with us on Facebook (American Diabetes Association), Twitter (@AmDiabetesAssn), and Instagram (@AmDiabetesAssn).
SOURCE American Diabetes Association
similar links
http://www.diabetes.org
